Rhabdomyolysis and acute kidney injury potentiated by a drug-drug interaction between cyclosporine, leflunomide, and rosuvastatin in a kidney transplant recipient: A …

J Korzec, R Strausbaugh, JJ Mikolay Jr… - Journal of the American …, 2024 - Elsevier
Background This study aimed to describe a case of rhabdomyolysis and acute kidney injury
potentiated by a drug-drug interaction (DDI) between cyclosporine, leflunomide, and …
相关文章

Rhabdomyolysis and acute kidney injury potentiated by a drug-drug interaction between cyclosporine, leflunomide, and rosuvastatin in a kidney transplant recipient: A …

J Korzec, R Strausbaugh, JJ Mikolay… - Journal of the American … - japha.org
Background This study aimed to describe a case of rhabdomyolysis and acute kidney injury
potentiated by a drug-drug interaction (DDI) between cyclosporine, leflunomide, and …

Rhabdomyolysis and acute kidney injury potentiated by a drug-drug interaction between cyclosporine, leflunomide, and rosuvastatin in a kidney transplant recipient: A …

J Korzec, R Strausbaugh, JJ Mikolay Jr… - Journal of the … - pubmed.ncbi.nlm.nih.gov
Background This study aimed to describe a case of rhabdomyolysis and acute kidney injury
potentiated by a drug-drug interaction (DDI) between cyclosporine, leflunomide, and …

[引用][C] Rhabdomyolysis and acute kidney injury potentiated by a drug-drug interaction between cyclosporine, leflunomide, and rosuvastatin in a kidney transplant …

J Korzec, R Strausbaugh, JJ Mikolay Jr… - Journal of the …, 2024 - europepmc.org
Rhabdomyolysis and acute kidney injury potentiated by a drug-drug interaction between
cyclosporine, leflunomide, and rosuvastatin in a kidney transplant recipient: A missed …